Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Proton vs. Photon Radiation Therapy for Primary Gliomas: An Analysis of the National Cancer Data Base.

Jhaveri J, Cheng E, Tian S, Buchwald Z, Chowdhary M, Liu Y, Gillespie TW, Olson JJ, Diaz AZ, Voloschin A, Eaton BR, Crocker IR, McDonald MW, Curran WJ, Patel KR.

Front Oncol. 2018 Nov 28;8:440. doi: 10.3389/fonc.2018.00440. eCollection 2018.

2.

Is less more? Comparing chemotherapy alone with chemotherapy and radiation for high-risk grade 2 glioma: An analysis of the National Cancer Data Base.

Jhaveri J, Liu Y, Chowdhary M, Buchwald ZS, Gillespie TW, Olson JJ, Voloschin AD, Eaton BR, Shu HG, Crocker IR, Curran WJ, Patel KR.

Cancer. 2018 Mar 15;124(6):1169-1178. doi: 10.1002/cncr.31158. Epub 2017 Dec 4.

PMID:
29205287
3.

Comparison of Adjuvant Radiation Therapy Alone and Chemotherapy Alone in Surgically Resected Low-Grade Gliomas: Survival Analyses of 2253 Cases from the National Cancer Data Base.

Wu J, Neale N, Huang Y, Bai HX, Li X, Zhang Z, Karakousis G, Huang R, Zhang PJ, Tang L, Xiao B, Yang L.

World Neurosurg. 2018 Apr;112:e812-e822. doi: 10.1016/j.wneu.2018.01.163. Epub 2018 Jan 31.

PMID:
29409888
4.

Utilization of neoadjuvant intensity-modulated radiation therapy and proton beam therapy for esophageal cancer in the United States.

Haque W, Verma V, Butler EB, Teh BS.

J Gastrointest Oncol. 2018 Apr;9(2):282-294. doi: 10.21037/jgo.2017.11.14.

5.

Comparative Outcomes After Definitive Chemoradiotherapy Using Proton Beam Therapy Versus Intensity Modulated Radiation Therapy for Esophageal Cancer: A Retrospective, Single-Institutional Analysis.

Xi M, Xu C, Liao Z, Chang JY, Gomez DR, Jeter M, Cox JD, Komaki R, Mehran R, Blum MA, Hofstetter WL, Maru DM, Bhutani MS, Lee JH, Weston B, Ajani JA, Lin SH.

Int J Radiat Oncol Biol Phys. 2017 Nov 1;99(3):667-676. doi: 10.1016/j.ijrobp.2017.06.2450. Epub 2017 Jun 27.

PMID:
29280461
6.

The role of postmastectomy radiotherapy in women with pathologic T3N0M0 breast cancer.

Cassidy RJ, Liu Y, Kahn ST, Jegadeesh NK, Liu X, Subhedar PD, Arciero CA, Gillespie TW, Torres MA.

Cancer. 2017 Aug 1;123(15):2829-2839. doi: 10.1002/cncr.30675. Epub 2017 Apr 7.

7.

Impact of intensity modulated radiation therapy on survival in anal cancer.

Jhaveri J, Rayfield L, Liu Y, Chowdhary M, Tian S, Cassidy RJ, Gillespie T, Patel PR, Landry JC, Patel KR.

J Gastrointest Oncol. 2018 Aug;9(4):618-630. doi: 10.21037/jgo.2018.05.07.

8.

Adjuvant Proton Beam Therapy in the Management of Thymoma: A Dosimetric Comparison and Acute Toxicities.

Parikh RR, Rhome R, Hug E, Tsai H, Cahlon O, Chon B, Goenka A.

Clin Lung Cancer. 2016 Sep;17(5):362-366. doi: 10.1016/j.cllc.2016.05.019. Epub 2016 Jun 8.

PMID:
27372386
9.

Patient characterization and usage trends of proton beam therapy for localized prostate cancer in the United States: A study of the National Cancer Database.

Amini A, Raben D, Crawford ED, Flaig TW, Kessler ER, Lam ET, Maroni P, Pugh TJ.

Urol Oncol. 2017 Jun;35(6):438-446. doi: 10.1016/j.urolonc.2017.01.013. Epub 2017 Feb 15.

PMID:
28214281
10.

Outcomes of multidisciplinary management in pediatric low-grade gliomas.

Oh KS, Hung J, Robertson PL, Garton HJ, Muraszko KM, Sandler HM, Hamstra DA.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e481-8. doi: 10.1016/j.ijrobp.2011.01.019. Epub 2011 Apr 4.

PMID:
21470783
11.

First Clinical Report of Proton Beam Therapy for Postoperative Radiotherapy for Non-Small-Cell Lung Cancer.

Remick JS, Schonewolf C, Gabriel P, Doucette A, Levin WP, Kucharczuk JC, Singhal S, Pechet TTV, Rengan R, Simone CB 2nd, Berman AT.

Clin Lung Cancer. 2017 Jul;18(4):364-371. doi: 10.1016/j.cllc.2016.12.009. Epub 2017 Jan 5.

PMID:
28162946
12.

Clinical outcomes and toxicities of proton radiotherapy for gastrointestinal neoplasms: a systematic review.

Verma V, Lin SH, Simone CB 2nd, Mehta MP.

J Gastrointest Oncol. 2016 Aug;7(4):644-64. doi: 10.21037/jgo.2016.05.06.

13.

Can we eliminate neoadjuvant chemoradiotherapy in favor of neoadjuvant multiagent chemotherapy for select stage II/III rectal adenocarcinomas: Analysis of the National Cancer Data base.

Cassidy RJ, Liu Y, Patel K, Zhong J, Steuer CE, Kooby DA, Russell MC, Gillespie TW, Landry JC.

Cancer. 2017 Mar 1;123(5):783-793. doi: 10.1002/cncr.30410. Epub 2016 Oct 25.

14.

Lymphocyte-Sparing Effect of Proton Therapy in Patients with Esophageal Cancer Treated with Definitive Chemoradiation.

Fang P, Shiraishi Y, Verma V, Jiang W, Song J, Hobbs BP, Lin SH.

Int J Part Ther. 2018 Winter;4(3):23-32. doi: 10.14338/IJPT-17-00033.1.

15.

Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation.

Zhong J, Patel K, Switchenko J, Cassidy RJ, Hall WA, Gillespie T, Patel PR, Kooby D, Landry J.

Cancer. 2017 Sep 15;123(18):3486-3493. doi: 10.1002/cncr.30706. Epub 2017 May 10.

16.

Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer.

Rwigema JM, Verma V, Lin L, Berman AT, Levin WP, Evans TL, Aggarwal C, Rengan R, Langer C, Cohen RB, Simone CB 2nd.

Cancer. 2017 Nov 1;123(21):4244-4251. doi: 10.1002/cncr.30870. Epub 2017 Jul 5.

17.

Proton beam therapy and concurrent chemotherapy for esophageal cancer.

Lin SH, Komaki R, Liao Z, Wei C, Myles B, Guo X, Palmer M, Mohan R, Swisher SG, Hofstetter WL, Ajani JA, Cox JD.

Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):e345-51. doi: 10.1016/j.ijrobp.2012.01.003. Epub 2012 Mar 13.

18.

Is Proton Therapy a "Pro" for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database.

Chowdhary M, Lee A, Gao S, Wang D, Barry PN, Diaz R, Bagadiya NR, Park HS, Yu JB, Wilson LD, Moran MS, Higgins SA, Knowlton CA, Patel KR.

Front Oncol. 2019 Jan 14;8:678. doi: 10.3389/fonc.2018.00678. eCollection 2018.

19.

Comparison of Radiation Therapy Alone and Chemotherapy Alone for Low-Grade Gliomas without Surgical Resection.

Wu J, Kim C, Bai HX, Tang L, Wang Y, Li X, Zhang Z, Karakousis G, Huang R, Zhang PJ, Xiao B, Yang L.

World Neurosurg. 2019 Feb;122:e108-e120. doi: 10.1016/j.wneu.2018.09.109. Epub 2018 Sep 24.

PMID:
30261385
20.

A Comparison of Grade 4 Lymphopenia With Proton Versus Photon Radiation Therapy for Esophageal Cancer.

Routman DM, Garant A, Lester SC, Day CN, Harmsen WS, Sanheuza CT, Yoon HH, Neben-Wittich MA, Martenson JA, Haddock MG, Hallemeier CL, Merrell KW.

Adv Radiat Oncol. 2019 Jan 17;4(1):63-69. doi: 10.1016/j.adro.2018.09.004. eCollection 2019 Jan-Mar.

Supplemental Content

Support Center